The new FDA warning is aimed at making information regarding rare heart risks clearer for young males after COVID-19 mRNA vaccines.
United States: The U.S. Food and Drug Administration has required Pfizer and Moderna to make their vaccine warning labels for COVID-19 more prominent, as reported by HealthDay.
Heart Inflammation Risk Prompts Label Update
Officials have updated the warnings after a link was found between Pfizer in teenage and young men and heart inflammation, as CBS News reported.
Information from FDA safety monitoring and a recent study leads the US government to issue this warning for males ages 16 to 25.
The Group offers both Pfizer’s Comirnaty and Moderna’s Spikevax vaccines.
A new note on the label explains that “the largest predicted number of cases of myocarditis and/or pericarditis is in males who are 16 to 25 years of age.”
What the Data Shows
Out of every million doses given to males aged 16 to 25, there were 38 cases of these heart conditions, the warning says. The rate for people under 65 was approximately 8 cases for every million doses, reports CBS News.
According to the U.S. Centers for Disease Control and Prevention (CDC), most cases start soon after the shot and usually improve shortly thereafter.
The FDA added that heart MRI scans in those with the condition usually revealed signs of getting better with time for most people.
“It is not known if these heart MRI findings might predict long-term heart effects of myocarditis,” the FDA said. “Studies are underway to find out if there are long-term heart effects in people who have had myocarditis after receiving an mRNA COVID-19 vaccine.”
🚨 Trump and RFK JR.'s FDA have just told Pfizer and Moderna to expand their warning labels on COVID-19 vaccines regarding the risk of HEART INJURY, especially for teen boys and young men – CBS
— Eric Daugherty (@EricLDaugh) May 21, 2025
TRANSPARENCY is here. pic.twitter.com/dOve78WEdA
CBS News stated that neither company has provided a statement so far.
The FDA made the letters public just before a U.S. Senate hearing on “how health officials downplayed and hid myocarditis and other adverse events associated with the COVID-19 vaccines.”
Transparency at the Forefront
Transparency is essential, according to a statement released by FDA spokesperson Andrew Nixon, as reported by HealthDay.
“Americans deserve radical transparency around the safety and efficacy of COVID vaccines, and the FDA is delivering on their promise to do just that,” the statement said. “Moderna and Pfizer should take steps to ensure that individuals are aware of COVID vaccine-related adverse events resulting in myocarditis and pericarditis.”